Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. (ACRS) — Form 8-K: Current report
About this filing
Aclaris Therapeutics, Inc. (ACRS) filed an 8-K on Oct 27, 2026 reporting entry into a material agreement (Item 1.01), with exhibits (Item 9.01).
Key facts
- Item 1.01 · Entry into a material agreement
- Item 9.01 · Financial statements and exhibits
More ACRS filings
- SC 13G/A
Filed Nov 16, 2026
- 8-K
Filed Nov 16, 2026
- 10-Q
Filed Nov 5, 2026
- 8-K
Filed Nov 5, 2026
- 424B5
Filed Oct 27, 2026
- 8-K
Filed Oct 27, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.